Matches in Wikidata for { <http://www.wikidata.org/entity/Q63596269> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q63596269 description "clinical trial" @default.
- Q63596269 description "ensayu clínicu" @default.
- Q63596269 description "klinisch onderzoek" @default.
- Q63596269 description "klinischer Forschung" @default.
- Q63596269 description "клінічне випробування" @default.
- Q63596269 name "An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcin" @default.
- Q63596269 type Item @default.
- Q63596269 label "An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcin" @default.
- Q63596269 prefLabel "An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcin" @default.
- Q63596269 P1050 Q63596269-50E65A3B-04CD-4460-B97A-BA08F40E916B @default.
- Q63596269 P1132 Q63596269-EF959557-C326-4BC5-815C-BC954EF475F9 @default.
- Q63596269 P131 Q63596269-12BCDE74-2628-47C9-B562-D5E278399313 @default.
- Q63596269 P1476 Q63596269-34065E0D-C727-4038-9DB4-CC51F8DD0EC3 @default.
- Q63596269 P17 Q63596269-10BA4369-DC58-4848-B611-8B6FC4F2589E @default.
- Q63596269 P17 Q63596269-20867889-EE45-409C-9FCE-188DBD9FA596 @default.
- Q63596269 P17 Q63596269-24B176F4-EE8B-48CD-AB95-A083E1B6F75A @default.
- Q63596269 P17 Q63596269-2910D000-52D0-42AF-A8FF-A1BFA6CB5287 @default.
- Q63596269 P17 Q63596269-2AAD1CDA-F68A-4F1D-A17C-D2DAE57686B1 @default.
- Q63596269 P17 Q63596269-3F0F9994-7E41-4421-840B-717F90D8E34D @default.
- Q63596269 P17 Q63596269-5CF7BFEB-3F49-4CD5-BB56-E4CE80E42E7C @default.
- Q63596269 P17 Q63596269-5D1B0E6F-0ABE-44BD-89AE-3922A663FE67 @default.
- Q63596269 P17 Q63596269-7428AC84-7A96-44D4-BC07-664781C9EC6B @default.
- Q63596269 P17 Q63596269-9A252780-AF7E-44F2-B9B5-F2CDD73AB97F @default.
- Q63596269 P17 Q63596269-EB4CD923-C9BE-489C-AB55-B2CB4D7D37BF @default.
- Q63596269 P17 Q63596269-F4F9A8C2-0D28-49E6-85D8-313B98DEAAD0 @default.
- Q63596269 P17 Q63596269-F72579E1-56D3-4AB6-8CD3-55DB1D0D0F65 @default.
- Q63596269 P2899 Q63596269-FBD3AD89-CADA-4686-986A-1AF07F651565 @default.
- Q63596269 P3098 Q63596269-4EB06A3B-F151-4FBC-B751-656F2FD0A643 @default.
- Q63596269 P31 Q63596269-727758C3-F71A-4302-88A5-86BB623439C3 @default.
- Q63596269 P4844 Q63596269-A22A8A56-92B3-4691-A566-91BBE7A48C80 @default.
- Q63596269 P4844 Q63596269-C7CDE3D1-1A59-48BD-9822-8BB624D8A8B5 @default.
- Q63596269 P4844 Q63596269-DC96B45D-7514-46D9-9A21-803F1308A957 @default.
- Q63596269 P580 Q63596269-2147962A-6D8E-486B-B979-9E5AC11C117C @default.
- Q63596269 P582 Q63596269-9D9964A6-8D60-4244-A807-1D27A81880DE @default.
- Q63596269 P6099 Q63596269-B78FA444-6049-4B9E-B1D0-231E0C01E355 @default.
- Q63596269 P8363 Q63596269-42D15F96-3D3E-4685-A2CA-6FEA72C1C50A @default.
- Q63596269 P859 Q63596269-6073AB09-FB2D-4E89-9951-33D24DCCE60C @default.
- Q63596269 P1050 Q356033 @default.
- Q63596269 P1132 "+610" @default.
- Q63596269 P131 Q1183 @default.
- Q63596269 P1476 "A Randomized, Active-Controlled, Open-Label, Phase 2 Clinical Trial of BMS-986213, in Combination With Various Standard-of-Care Therapeutic Regimens, in Participants With Recurrent, Locally Advanced, or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction (GEJ) Adenocarcinoma" @default.
- Q63596269 P17 Q155 @default.
- Q63596269 P17 Q16 @default.
- Q63596269 P17 Q183 @default.
- Q63596269 P17 Q218 @default.
- Q63596269 P17 Q29 @default.
- Q63596269 P17 Q298 @default.
- Q63596269 P17 Q30 @default.
- Q63596269 P17 Q38 @default.
- Q63596269 P17 Q408 @default.
- Q63596269 P17 Q414 @default.
- Q63596269 P17 Q45 @default.
- Q63596269 P17 Q739 @default.
- Q63596269 P17 Q96 @default.
- Q63596269 P2899 "+18" @default.
- Q63596269 P3098 "NCT03704077" @default.
- Q63596269 P31 Q30612 @default.
- Q63596269 P4844 Q423762 @default.
- Q63596269 P4844 Q7041828 @default.
- Q63596269 P4844 Q7290345 @default.
- Q63596269 P580 "2019-06-15T00:00:00Z" @default.
- Q63596269 P582 "2021-01-03T00:00:00Z" @default.
- Q63596269 P6099 Q42824440 @default.
- Q63596269 P8363 Q78089383 @default.
- Q63596269 P859 Q266423 @default.